Search company, investor...




Total Raised


Date of IPO


About Nucien

Developer of anti infectious drugs, cardiovascular drugs, and anti cancer drugs.

Headquarters Location

1 Kangli Road

Changsha, Hunan, 510530,


86 20 38952013

Missing: Nucien's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nucien's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Nucien

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nucien is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Nucien Frequently Asked Questions (FAQ)

  • Where is Nucien's headquarters?

    Nucien's headquarters is located at 1 Kangli Road, Changsha.

  • What is Nucien's latest funding round?

    Nucien's latest funding round is IPO.

  • How much did Nucien raise?

    Nucien raised a total of $19.77M.

  • Who are the investors of Nucien?

    Investors of Nucien include CDH Investments and Xiangjiang Liyuan.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.